Swiss regulator approves blood safety system from Cerus

08/19/2009 | Reuters

Swissmedic granted approval to Cerus' Intercept blood system, which inactivates viruses, bacteria and other blood-borne pathogens in blood components used for transfusion. The company said the approval allows Intercept-treated platelets to be stored for a week.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC